
Current Price | $0.92 | Mkt Cap | $82.8M |
---|---|---|---|
Open | $0.84 | P/E Ratio | -0.67 |
Prev. Close | $0.92 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $0.78 - $0.94 | Volume | 935 |
52-Wk Range | $0.78 - $15.90 | Avg. Daily Vol. | 1,034,205 |
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers.
Current Price | $0.92 | Mkt Cap | $82.8M |
---|---|---|---|
Open | $0.84 | P/E Ratio | -0.67 |
Prev. Close | $0.92 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $0.78 - $0.94 | Volume | 935 |
52-Wk Range | $0.78 - $15.90 | Avg. Daily Vol. | 1,034,205 |
The best Bull and Bear pitches based on recency and number of recommendations.
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about VERU.
Recs
Veru has a unique situation. a drug that stops death from covid 55% of the time or more. It also stops any variant.by dismantling the cytokine cloud so covid can not get to your lungs. They have been used for emergency situations for some time and they should easily pass the FDA requirements. they also have 2 or 3 drugs in the pipeline for prostate cancer and breast cancer. They have 2 more drugs which have been funding their research so they make some money which isn't used as for instance a p/e ratio. Look for higher prices on this company and stock.
Recs
Their sabizabulin drug has been submitted for emergency authorized use to the FDA. The drug was successful in reducing deaths by over 50% in severe COVID patients. If successful, this drug will save many lives and generate plenty of revenue to complete their research/trials of their oncology treatments which also uses some parts of sabizabulin.
Find the members with the highest scoring picks in VERU.
TMFdjagielski (38.78) Score: +109.58
The Score Leader is the player with the highest score across all their picks in VERU.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
TMFdjagielski | 38.78 | 9/23/2022 |
![]() |
1Y | $10.44 | -91.21% | +18.37% | +109.58 | 0 Comment | |
TMFGBudwell | < 20 | 8/25/2022 |
![]() |
5Y | $18.14 | -94.94% | +5.64% | -100.58 | 0 Comment | |
alvinpall | 53.09 | 10/14/2022 |
![]() |
3Y | $11.48 | -92.01% | +19.02% | -111.03 | 1 Comment | |
lemiwinx | < 20 | 7/14/2022 |
![]() |
5Y | $15.41 | -94.05% | +17.50% | -111.55 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.